[The role of the kallikrein-kinin and renin-angiotensin-aldosterone systems in the development of hypertension in glomerulonephritis]
- PMID: 2084330
[The role of the kallikrein-kinin and renin-angiotensin-aldosterone systems in the development of hypertension in glomerulonephritis]
Abstract
A total of 74 patients with various clinicomorphological variants of glomerulonephritis (GN) were examined. Only a high activity of the enzyme kinase-1 that destroys kinins and the kallikrein inhibitors alpha 1-antitrypsin, alpha 2-macroglobulin is a contribution of the kallikrein-kinin system made to the general antihypertensive "armoury" of the body, as shown by the study. The correlation between the kallikrein activity and the active renin/total renin ratio predetermines that kallikrein may participate in endogenous plasma renin activation in GN patients. In this case, the vasoconstrictive effect of renin may limit the antihypertensive action of kallikrein and kinins by a feedback mechanism.
Similar articles
-
[Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].Ann Acad Med Stetin. 1996;42:123-38. Ann Acad Med Stetin. 1996. PMID: 9199117 Clinical Trial. Polish.
-
[Renin-aldosterone system in patients with hypertensive form of chronic glomerulonephritis and preserved renal function].Klin Med (Mosk). 2009;87(8):61-3. Klin Med (Mosk). 2009. PMID: 19827534 Russian.
-
The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.Clin Nephrol. 1994 Nov;42(5):300-8. Clin Nephrol. 1994. PMID: 7851031
-
The plasma kallikrein/kinin and renin angiotensin systems in blood pressure regulation in sepsis.J Endotoxin Res. 2004;10(1):3-13. doi: 10.1179/096805104225003807. J Endotoxin Res. 2004. PMID: 15025819 Review.
-
Cross-talk of the renin-angiotensin and kallikrein-kinin systems.Biol Chem. 2006 Feb;387(2):145-50. doi: 10.1515/BC.2006.019. Biol Chem. 2006. PMID: 16497145 Review.